1352642-02-4Relevant articles and documents
VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES
-
Page/Page column 55; 56, (2021/07/24)
The present invention provides antibody-payload conjugates having a payload-to-antibody ratio of 1. The antibody-payload conjugate having structure (1): Formula (1) wherein: - a, b and c are each independently 0 or 1; - L1, L2 and L3 are linkers; - D is a payload; - BM is a branching moiety; - Z are connecting groups obtainable by a cycloaddition reaction. The invention further provides a method for preparing the antibody-payload conjugate according to the invention, an intermediate compound in that preparation method, and medical uses of the antibody-payload conjugate according to the invention.
VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES
-
Page/Page column 57, (2021/07/24)
The present invention provides antibody-payload conjugates having a payload-to-antibody ratio of 1. The antibody-payload conjugate is according to structure (1): formula (1), wherein: - a, b, c and d are each independently 0 or 1; - e is an integer in the
MOLECULAR LOGIC GATES FOR CONTROLLED MATERIAL DEGRADATION
-
Page/Page column 39; 82; 83, (2018/04/20)
The present disclosure features, inter alia, a cyclic multifunctional linker, including at least two cleavable moieties; at least two connecting chains connected to the at least two cleavable moieties to provide a cyclic structure; and at least two linkin